Matches in Wikidata for { <http://www.wikidata.org/entity/Q91444588> ?p ?o ?g. }
Showing items 1 to 70 of
70
with 100 items per page.
- Q91444588 description "article scientifique (publié 2019)" @default.
- Q91444588 description "artikull shkencor i botuar më 01 janar 2019" @default.
- Q91444588 description "artículu científicu espublizáu en xineru de 2019" @default.
- Q91444588 description "im Januar 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91444588 description "scientific article published on 01 January 2019" @default.
- Q91444588 description "wetenschappelijk artikel" @default.
- Q91444588 description "наукова стаття, опублікована 1 січня 2019" @default.
- Q91444588 description "научна статия" @default.
- Q91444588 name "Results from a 78-week, single-arm, open-label phase 2 study to evaluate UX007 in pediatric and adult patients with severe long-chain fatty acid oxidation disorders (LC-FAOD)" @default.
- Q91444588 name "Results from a 78-week, single-arm, open-label phase 2 study to evaluate UX007 in pediatric and adult patients with severe long-chain fatty acid oxidation disorders (LC-FAOD)" @default.
- Q91444588 name "Results from a 78-week, single-arm, open-label phase 2 study to evaluate UX007 in pediatric and adult patients with severe long-chain fatty acid oxidation disorders (LC-FAOD)" @default.
- Q91444588 type Item @default.
- Q91444588 label "Results from a 78-week, single-arm, open-label phase 2 study to evaluate UX007 in pediatric and adult patients with severe long-chain fatty acid oxidation disorders (LC-FAOD)" @default.
- Q91444588 label "Results from a 78-week, single-arm, open-label phase 2 study to evaluate UX007 in pediatric and adult patients with severe long-chain fatty acid oxidation disorders (LC-FAOD)" @default.
- Q91444588 label "Results from a 78-week, single-arm, open-label phase 2 study to evaluate UX007 in pediatric and adult patients with severe long-chain fatty acid oxidation disorders (LC-FAOD)" @default.
- Q91444588 prefLabel "Results from a 78-week, single-arm, open-label phase 2 study to evaluate UX007 in pediatric and adult patients with severe long-chain fatty acid oxidation disorders (LC-FAOD)" @default.
- Q91444588 prefLabel "Results from a 78-week, single-arm, open-label phase 2 study to evaluate UX007 in pediatric and adult patients with severe long-chain fatty acid oxidation disorders (LC-FAOD)" @default.
- Q91444588 prefLabel "Results from a 78-week, single-arm, open-label phase 2 study to evaluate UX007 in pediatric and adult patients with severe long-chain fatty acid oxidation disorders (LC-FAOD)" @default.
- Q91444588 P1433 Q91444588-7E5C0EED-E671-40C4-B691-5F7104FF7B85 @default.
- Q91444588 P1476 Q91444588-83497A6A-7704-427F-ADF1-19620982BF57 @default.
- Q91444588 P2093 Q91444588-17A02A6D-5FBD-4D83-BE48-F11F7EC22322 @default.
- Q91444588 P2093 Q91444588-232F4974-88A0-41FE-8AD7-ACEBF176B424 @default.
- Q91444588 P2093 Q91444588-2BBDDBA1-24E3-4988-B30D-F1FE6EFCC00D @default.
- Q91444588 P2093 Q91444588-2F271478-8752-4251-81BB-D2306BB55287 @default.
- Q91444588 P2093 Q91444588-598D383A-3E6B-4AC8-96EA-F07B519EE99D @default.
- Q91444588 P2093 Q91444588-5F3CB871-CD10-4D7E-8CD4-EC8C07A66D22 @default.
- Q91444588 P2093 Q91444588-66B72A3C-CD85-48CD-AEC7-333902BDBD42 @default.
- Q91444588 P2093 Q91444588-7FDDA597-073D-464E-A5CA-0977FA77B031 @default.
- Q91444588 P2093 Q91444588-9BCBD044-1A80-4DD0-8B8F-6CF7DE9A8AA3 @default.
- Q91444588 P2093 Q91444588-AA63EDF3-0B6A-4CD5-8127-A3EFA81ECA9F @default.
- Q91444588 P2093 Q91444588-C3EB5F36-D38D-4BE7-8AC1-5658B417CF25 @default.
- Q91444588 P2093 Q91444588-CE6EA9F0-9D6D-4B19-A7FA-0DEF41B296E7 @default.
- Q91444588 P2093 Q91444588-D93E71CE-F546-4EF7-8C82-6292A6C5E61D @default.
- Q91444588 P2093 Q91444588-E8C2A8C6-5E3A-43D6-8FF6-58A378DCBD42 @default.
- Q91444588 P304 Q91444588-8800427C-2B1C-4879-9624-C2BFFEFE0C34 @default.
- Q91444588 P31 Q91444588-68B905E0-8DC7-456C-BBE0-398AE89982FB @default.
- Q91444588 P356 Q91444588-8A3837BC-1E6F-4D6D-813C-D18C231690F5 @default.
- Q91444588 P433 Q91444588-80B57DD7-4051-4552-9BB4-69C6366CA3EA @default.
- Q91444588 P478 Q91444588-80F1A794-8421-4C48-B9B0-1567728416BD @default.
- Q91444588 P50 Q91444588-B3640D71-9330-49D3-AEB3-AF7EECCD3552 @default.
- Q91444588 P577 Q91444588-BBAB5DF8-3B3E-42A9-8428-0EE42B949A81 @default.
- Q91444588 P698 Q91444588-9C6FCF12-1136-4ADB-9798-3E5283EAD978 @default.
- Q91444588 P932 Q91444588-5E030A48-3565-4073-A2FD-105F0E3179DF @default.
- Q91444588 P356 JIMD.12038 @default.
- Q91444588 P698 30740733 @default.
- Q91444588 P1433 Q6295359 @default.
- Q91444588 P1476 "Results from a 78-week, single-arm, open-label phase 2 study to evaluate UX007 in pediatric and adult patients with severe long-chain fatty acid oxidation disorders (LC-FAOD)" @default.
- Q91444588 P2093 "Alexandra Bowden" @default.
- Q91444588 P2093 "Amarilis Sanchez-Valle" @default.
- Q91444588 P2093 "Barbara Burton" @default.
- Q91444588 P2093 "Chao-Yin Chen" @default.
- Q91444588 P2093 "Deborah Marsden" @default.
- Q91444588 P2093 "Elaine Murphy" @default.
- Q91444588 P2093 "Emil Kakkis" @default.
- Q91444588 P2093 "Jason Cataldo" @default.
- Q91444588 P2093 "Jerry Vockley" @default.
- Q91444588 P2093 "John Phillips" @default.
- Q91444588 P2093 "Nicola Longo" @default.
- Q91444588 P2093 "Pranoot Tanpaiboon" @default.
- Q91444588 P2093 "Stephanie Grunewald" @default.
- Q91444588 P2093 "Wencong Chen" @default.
- Q91444588 P304 "169-177" @default.
- Q91444588 P31 Q13442814 @default.
- Q91444588 P356 "10.1002/JIMD.12038" @default.
- Q91444588 P433 "1" @default.
- Q91444588 P478 "42" @default.
- Q91444588 P50 Q42614948 @default.
- Q91444588 P577 "2019-01-01T00:00:00Z" @default.
- Q91444588 P698 "30740733" @default.
- Q91444588 P932 "6348052" @default.